ALC
PFE icon

Alexander Labrunerie & Co’s Pfizer PFE Stock Holding History

Alexander Labrunerie & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,941
Closed -$1.5M – 122
2025
Q2 		$1.5M Sell
61,941
-203
-0.3% -$4.73K 0.62% 36
2025
Q1 		$1.57M Buy
62,144
+16,367
+36% +$428K 0.68% 35
2024
Q4 		$1.21M Buy
45,777
+681
+2% +$18.5K 0.54% 38
2024
Q3 		$1.31M Sell
45,096
-240
-0.5% -$7K 0.6% 37
2024
Q2 		$1.27M Buy
45,336
+7,327
+19% +$202K 0.68% 32
2024
Q1 		$1.05M Buy
+38,009
New +$1.05M 0.59% 34

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Alexander Labrunerie & Co's PFE Position: Q3 2025 in Review

Alexander Labrunerie & Co sold out of Pfizer (PFE) in Q3 2025, closing a stake of 61,941 shares — an estimated $1.5M sold.

Alexander Labrunerie & Co first reported a position in PFE in Q1 2024 and held it in 6 quarters. The position peaked at $1.57M in Q1 2025. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Alexander Labrunerie & Co reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Alexander Labrunerie & Co sold 61,941 Pfizer shares in Q3 2025, an estimated $1.5M.
  • Alexander Labrunerie & Co first reported a position in Pfizer in Q1 2024 and held it in 6 quarters.
  • Alexander Labrunerie & Co's Pfizer position peaked at $1.57M in Q1 2025.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Alexander Labrunerie & Co's 13F filing for Q3 2025, filed 25 Nov 2025.